Clinical performance of the BD onclarity extended genotyping assay for the management of women positive for human papillomavirus in cervical cancer screening
KD Volesky, S Magnan, MH Mayrand, SD Isidean… - … Biomarkers & Prevention, 2022 - AACR
Background: Among women whose cervical specimens tested positive for high-risk human
papillomaviruses (hrHPV) via the Hybrid Capture 2 assay in the Canadian Cervical Cancer …
papillomaviruses (hrHPV) via the Hybrid Capture 2 assay in the Canadian Cervical Cancer …
The importance of high-risk human papillomavirus types other than 16 and 18 in cervical neoplasia
IA Robadi, M Pharaon… - Archives of pathology & …, 2018 - meridian.allenpress.com
Context.—Types 16 and 18 are the most widely studied high-risk types of human
papillomavirus (HPV). However, other high-risk HPV types (HPV non-16/18) also play a …
papillomavirus (HPV). However, other high-risk HPV types (HPV non-16/18) also play a …
Prevalence of human papillomavirus infection among women in rural Nepal
S Shakya, U Syversen, BO Åsvold… - Acta obstetricia et …, 2017 - Wiley Online Library
Introduction In this study we aimed to determine the overall and type‐specific prevalence of
cervical human papillomavirus (HPV) infection and risk factors for such infection among …
cervical human papillomavirus (HPV) infection and risk factors for such infection among …
[HTML][HTML] Detection of high-grade cervical neoplasia using extended genotyping: Performance data from the longitudinal phase of the Onclarity trial
MH Stoler, TC Wright Jr, V Parvu, K Yanson… - Gynecologic …, 2023 - Elsevier
Abstract Objectives The Onclarity cervical cancer screening trial was designed to establish
the clinical validity of the Onclarity HPV assay for extended genotyping (xGT) during …
the clinical validity of the Onclarity HPV assay for extended genotyping (xGT) during …
Accelerating cervical cancer screening with human papillomavirus genotyping
GF Sawaya, M Saraiya, A Soman, SV Gopalani… - American Journal of …, 2023 - Elsevier
Introduction Selective utilization of human papillomavirus (HPV) genotyping in cervical
cancer screening can accelerate clinical management, leading to earlier identification and …
cancer screening can accelerate clinical management, leading to earlier identification and …
Machine learning interpretation of extended human papillomavirus genotyping by Onclarity in an Asian cervical cancer screening population
This study aimed (i) to compare the performance of the BD Onclarity human papillomavirus
(HPV) assay with the Cobas HPV test in identifying cervical intraepithelial neoplasia 2/3 or …
(HPV) assay with the Cobas HPV test in identifying cervical intraepithelial neoplasia 2/3 or …
The effectiveness of human papillomavirus load, reflected by cycle threshold values, for the triage of HPV-positive self-samples in cervical cancer screening
F Song, H Du, C Wang, X Huang, X Qu… - Journal of medical …, 2021 - journals.sagepub.com
Objective The performance of Cobas4800 cycle threshold value (Ct-value, reflecting viral
load) combined with human papillomavirus (HPV) 16/18 genotyping was explored as a …
load) combined with human papillomavirus (HPV) 16/18 genotyping was explored as a …
Good performance of p16/Ki‐67 dual‐stain cytology for detection and post‐treatment surveillance of high‐grade CIN/VAIN in a prospective, cross‐sectional study
W Liu, J Gong, H Xu, D Zhang, N Xia, H Li… - Diagnostic …, 2020 - Wiley Online Library
Background The limited sensitivity of Papanicolaou (Pap) cytology and the low specificity of
HPV testing in detecting cervical or vaginal lesions means that either precancers are missed …
HPV testing in detecting cervical or vaginal lesions means that either precancers are missed …
Extended Genotyping to Stratify the Risk of CIN2+ in Women with Persistent HPV Infection, Negative Cytology and Type 3 Transformation Zone
MT Bruno, G Valenti, AG Cavallaro, I Palermo, T Aiello… - Cancers, 2024 - mdpi.com
Simple Summary Persistently hrHPV-positive women with negative cytology and zone
transformation type 3 are at increased risk of being diagnosed with CIN2+. The presence of …
transformation type 3 are at increased risk of being diagnosed with CIN2+. The presence of …
Risk Profile of High-grade Cervical Lesions and Cervical Cancer Considering the Combination of Cytology, HPV Genotype, and Age among Women Undergoing …
JC Possati-Resende, TZ Fritsch… - Revista Brasileira de …, 2023 - thieme-connect.com
Objective The present study aims to establish a risk profile for high-grade cervical lesions
and cervical cancer (CIN2+) in women undergoing colposcopy at the Hospital do Câncer de …
and cervical cancer (CIN2+) in women undergoing colposcopy at the Hospital do Câncer de …